Overview

A Study of Benzonatate Soft Capsule in Chinese Healthy Subjects

Status:
Unknown status
Trial end date:
2019-04-30
Target enrollment:
Participant gender:
Summary
Objective to study the pharmacokinetic, safety and efficacy of Single-dose and multiple-dose of benzonatate in Chinese healthy male and female subjects.
Phase:
Phase 1
Details
Lead Sponsor:
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Treatments:
Benzonatate